RBCL (RBC Life Sciences) Total Liabilities: $5.38 Mil (As of Jun. 2017)


What is RBC Life Sciences Total Liabilities?

RBC Life Sciences RBCL +0.14% Total Liabilities is $5.38 Mil as of Jun. 2017.

RBC Life Sciences's Total Liabilities for the quarter that ended in Jun. 2017 was $5.38 Mil.

RBC Life Sciences's quarterly Total Liabilities increased from Dec. 2016 ($3.83 Mil) to Mar. 2017 ($4.48 Mil) and increased from Mar. 2017 ($4.48 Mil) to Jun. 2017 ($5.38 Mil).

RBC Life Sciences's annual Total Liabilities declined from Dec. 2014 ($7.57 Mil) to Dec. 2015 ($3.42 Mil) but then increased from Dec. 2015 ($3.42 Mil) to Dec. 2016 ($3.83 Mil).

RBC Life Sciences Total Liabilities Historical Data

* Premium members only.

The historical data trend for RBC Life Sciences's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RBC Life Sciences Total Liabilities Chart

RBC Life Sciences Annual Data
Trend Dec07 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15 Dec16
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 8.50 8.52 7.57 3.42 3.83

RBC Life Sciences Quarterly Data
Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15 Mar16 Jun16 Sep16 Dec16 Mar17 Jun17
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.08 3.93 3.83 4.48 5.38

RBC Life Sciences Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

RBC Life Sciences's Total Liabilities for the fiscal year that ended in Dec. 2016 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=3.369+(0+0.00099999999999972
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0.461+0+0)
=3.83

Total Liabilities=Total Assets (A: Dec. 2016 )-Total Equity (A: Dec. 2016 )
=10.961-7.13
=3.83

RBC Life Sciences's Total Liabilities for the quarter that ended in Jun. 2017 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=5.09+(0+-5.5511151231258E-17
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0.287+0+0)
=5.38

Total Liabilities=Total Assets (Q: Jun. 2017 )-Total Equity (Q: Jun. 2017 )
=12.293-6.916
=5.38

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $5.38 Mil mean?
RBC Life Sciences (RBCL) has a Total Liabilities of $5.38 Mil as of Jun. 2017. The total amount of liabilities as recorded on a company's balance sheet. View historical data for RBC Life Sciences and its competitors.
Is RBC Life Sciences' Total Liabilities too high?
RBC Life Sciences' current Total Liabilities is $5.38 Mil.
How does RBC Life Sciences' Total Liabilities compare to SKVI and TISUQ?
RBC Life Sciences' Total Liabilities of $5.38 Mil can be compared against companies in the Consumer Packaged Goods industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Consumer Packaged Goods company?
A good Total Liabilities depends on the Consumer Packaged Goods industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for RBC Life Sciences and its competitors. RBC Life Sciences's current Total Liabilities is $5.38 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RBC Life Sciences stock overvalued right now?
RBC Life Sciences (RBCL) has a current Total Liabilities of $5.38 Mil. The current Total Liabilities is $5.38 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For RBC Life Sciences (RBCL), the current Total Liabilities is $5.38 Mil as of Jun. 2017. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

RBC Life Sciences Business Description

Address 2301 Crown Court, Irving, TX, USA, 75038
RBC Life Sciences Inc, through its subsidiaries, is engaged in marketing and distribution of nutritional supplements and personal care products. Its products include herbal formulas, vitamins, minerals, antioxidants, and skin, hair and body care products. It also markets its Nutritional Products in certain international markets through license arrangements. In addition to its Nutritional Products, the company also markets a line of wound care products under the MPM Medical brand name through a U.S. subsidiary.